Standard BioTools Releases Financial Performance for Q3 2025
November 4, 2025 - 20:32
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 -- Standard BioTools Inc. has announced its financial results for the third quarter ending September 30, 2025. The company reported a total combined revenue of $46.2 million for the quarter, with revenue from continuing operations reaching $19.6 million.
In a strategic move to enhance operational efficiency, Standard BioTools has implemented a comprehensive restructuring plan aimed at generating over $40 million in annualized cost savings. This initiative is part of the company's broader strategy to streamline operations and improve financial performance.
Furthermore, the company is on track to achieve its target of positive adjusted EBITDA, reflecting its commitment to financial health and sustainability. These results underscore Standard BioTools' efforts to navigate the evolving market landscape and position itself for future growth. The company remains focused on delivering value to its stakeholders while adapting to the challenges and opportunities within the biotechnology sector.
MORE NEWS
October 5, 2026 - 04:20
Talk Money Before You Travel: The Case for "Cash Yapping"Planning a group vacation often starts with picking a destination, booking flights and arguing over who gets the window seat. What many friend groups skip is the awkward part: figuring out how to...
October 4, 2026 - 01:09
Nvidia (NVDA) Is At The Center Of An $8 Billion AI Financing ShiftAmazon has created an $8 billion special purpose vehicle to purchase Nvidia Grace Blackwell chips and lease them back to AWS clients. The arrangement works as an off balance sheet financing tool...
October 3, 2026 - 20:14
Aston Villa under 'great stress' after 'settlement agreement'Aston Villa is reportedly operating under considerable strain after entering into a settlement agreement, according to recent developments surrounding the club. The situation has drawn attention...
October 3, 2026 - 05:30
NLY 8-K & SEC FilingsAnnaly Capital Management, known by its ticker symbol NLY, continues to provide shareholders and potential investors with detailed financial disclosures through its filings with the Securities and...